Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. Equijohn's stock talk Message Board

$NEO Headlines Biotech analysts lukewarm on diag

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 5326
Posted On: 12/11/2013 12:23:42 PM
Avatar
Posted By: Stock_Tracker
$NEO Headlines

Biotech analysts lukewarm on diagnostic stocks 3:16 p.m. Sept. 29, 2011 - Val Brickates Kennedy

10-Q: NEOGENOMICS INC 8:57 a.m. Oct. 30, 2013 - Edgar Online - (EDG = 10Q, 10K)
Neogenomics Management Discusses Q3 2013 Results - Earnings Call Transcript 3:10 p.m. Oct. 23, 2013 - Seeking Alpha
Neogenomics: A Low Risk, High Return Stock To Own 7:47 a.m. Sept. 30, 2013 - Seeking Alpha
4 Healthcare Stock Stories Offering Investment Wellness Today 8:22 p.m. Sept. 26, 2013 - Wall St. Cheat Sheet
10-Q: NEOGENOMICS INC 10:26 a.m. Aug. 2, 2013 - Edgar Online - (EDG = 10Q, 10K)
Earning 25% In Six Weeks - A Russell 2000 Update 7:37 a.m. May 20, 2013 - Seeking Alpha
10-Q: NEOGENOMICS INC 5:36 a.m. May 13, 2013 - Edgar Online - (EDG = 10Q, 10K)
Trades To Profit From The Coming Russell 2000 Rebalancing 6:27 a.m. April 8, 2013 - Seeking Alpha
NeoGenomics: Poised To Grow Further In 2013 And Beyond 1:52 p.m. Feb. 28, 2013 - Seeking Alpha
NeoGenomics: What Can We Expect for 2013 - Analyst Blog 12:37 p.m. Feb. 28, 2013 - Zacks.com
Biotech and Bioheath Stocks Raising Capital, Secondary Offerings 8:40 a.m. Feb. 22, 2013 - 247WallSt.com
10-K: NEOGENOMICS INC 11:18 a.m. Feb. 21, 2013 - Edgar Online - (EDG = 10Q, 10K)
3 Small Cap Biotech Plays Potentially Facing Cash-Flow Issues 7:30 a.m. Feb. 18, 2013 - Seeking Alpha
NeoGenomics' CEO Discusses Q4 2012 Results - Earnings Call Transcript 7:23 a.m. Feb. 15, 2013 - Seeking Alpha
Response Genetics' Competitors: Who To Watch, Who To Worry About 12:01 p.m. Feb. 8, 2013 - Seeking Alpha
NeoGenomics Is Poised to Grow in 2013 - Analyst Blog 10:38 a.m. Dec. 28, 2012 - Zacks.com
NeoGenomics is Poised to Grow further in 2013 - Analyst Blog 10:19 a.m. Dec. 18, 2012 - Zacks.com
Biotechs to Watch at the 2012 San Francisco Healthcare Confrences - Analyst Blog 6:14 a.m. Jan. 9, 2012 - Zacks.com
NGNM: initiating coverage with Outperform rating - Analyst Blog 11:01 a.m. Oct. 18, 2011 - Zacks.com

Covance Central Laboratories and NeoGenomics Enter into Exclusive Alliance to Provide Comprehensive Anatomic Pathology, Histology and Specialty Laboratory Testing Services for Clinical Trials 7:00 a.m. Nov. 18, 2013 - PR Newswire
NeoGenomics Reports Record Revenue of $16.9 Million, Adjusted EBITDA of $2.2 Million and Net Income of $900K for the Third Quarter 2013 6:00 a.m. Oct. 23, 2013 - PR Newswire
NeoGenomics to Host Third Quarter Earnings Webcast Live on Wednesday, October 23, 2013 8:31 a.m. Oct. 22, 2013 - ACCESSWIRE
NeoGenomics Schedules its Q3 2013 Earnings Release for October 23, 2013 1:11 p.m. Oct. 7, 2013 - PR Newswire
NeoGenomics Revises Upward its Quarter 3 2013 Guidance 6:00 a.m. Sept. 26, 2013 - PR Newswire
NeoGenomics Reports Revenue of $15.6 Million, Adjusted EBITDA of $1.8 Million and Earnings per share of $0.01 for the Second Quarter 2013 6:00 a.m. July 31, 2013 - PR Newswire
NeoGenomics Introduces Comprehensive Myelodysplastic Syndrome (MDS) Molecular Testing 6:00 a.m. July 25, 2013 - PR Newswire
NeoGenomics Schedules its Q2 2013 Earnings Release for July 31, 2013 11:17 a.m. July 15, 2013 - PR Newswire
NeoGenomics Reports Record Quarterly Revenue of $15.7 Million, Adjusted EBITDA of $1.8 Million and 46.3% Gross Margin for the First Quarter 6:00 a.m. April 25, 2013 - PR Newswire
NeoGenomics Schedules its Q1 2013 Earnings Release for April 25, 2013 2:00 p.m. April 17, 2013 - PR Newswire
NeoGenomics Reports 181% Increase in Adjusted EBITDA on 38% Revenue Growth and Achieves Profitability in 2012 7:00 a.m. Feb. 14, 2013 - PR Newswire
NeoGenomics Schedules its Q4 and Full Year 2012 Earnings Release for February 14, 2013 2:25 p.m. Feb. 5, 2013 - PR Newswire
NeoGenomics Validates and Launches NeoSITE(TM) Barrett's Esophagus FISH Test for Surveillance and Diagnosis of High Grade Dysplasia/Esophageal Cancer 7:00 a.m. Dec. 17, 2012 - PR Newswire
NeoGenomics Inc. [NEO] to Ring The NASDAQ Stock Market Closing Bell 10:00 a.m. Dec. 12, 2012 - GlobeNewswire


(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us